Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry*
暂无分享,去创建一个
Ole N Jensen | Henrik J Ditzel | H. Ditzel | A. Laenkholm | D. Tarin | O. Jensen | Rikke Leth-Larsen | R. Leth-Larsen | R. Lund | David Tarin | Anne-Vibeke Laenkholm | Rikke Lund | Helle V Hansen | H. Hansen
[1] Kai A Reidegeld,et al. An easy‐to‐use Decoy Database Builder software tool, implementing different decoy strategies for false discovery rate calculation in automated MS/MS protein identifications , 2008, Proteomics.
[2] D. Tarin,et al. Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency. , 2006, The American journal of pathology.
[3] J. Bunkenborg,et al. Database‐independent, database‐dependent, and extended interpretation of peptide mass spectra in VEMS V2.0 , 2004, Proteomics.
[4] A. Berrebi,et al. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. , 2006, Blood.
[5] P. Möller,et al. Expression of ecto-5'-nucleotidase (CD73) in normal mammary gland and in breast carcinoma. , 1991, British Journal of Cancer.
[6] A. Sonnenberg,et al. Integrin binding specificity of laminin-10/11: laminin-10/11 are recognized by α3β1, α6β1 and α6β4 integrins , 2000 .
[7] David M. Goldenberg,et al. CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy , 2004, Clinical Cancer Research.
[8] Eric O Long,et al. The complete sequence of the mRNA for the HLA‐DR‐associated invariant chain reveals a polypeptide with an unusual transmembrane polarity. , 1984, The EMBO journal.
[9] P. van Endert,et al. Human major histocompatibility complex class II invariant chain is expressed on the cell surface. , 1990, The Journal of biological chemistry.
[10] J. Bartek,et al. HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours. , 1987, British Journal of Cancer.
[11] H. Yee,et al. Enhanced Expression of a Novel Protein in Human Cancer Cells: A Potential Aid to Cancer Diagnosis , 2004, Cell Biology and Toxicology.
[12] R. Juliano,et al. Integrin Signaling , 2005, Cancer and Metastasis Reviews.
[13] Kenneth M. Yamada,et al. Fibronectin and integrins in invasion and metastasis , 1995, Cancer and Metastasis Reviews.
[14] L. Leng,et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. , 2006, Immunity.
[15] A. Ouhtit,et al. Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells , 2006, Oncogene.
[16] M. Maio,et al. Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach? , 2003, Oncogene.
[17] D. Tarin,et al. Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines. , 2001, Anticancer research.
[18] M. Mann,et al. Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.
[19] L. Shaw,et al. The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice. , 1997, The American journal of pathology.
[20] D. Larhammar,et al. cDNA clone for the human invariant gamma chain of class II histocompatibility antigens and its implications for the protein structure. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[22] A. Sonnenberg,et al. Integrin binding specificity of laminin-10/11: laminin-10/11 are recognized by alpha 3 beta 1, alpha 6 beta 1 and alpha 6 beta 4 integrins. , 2000, Journal of cell science.
[23] Chad J. Creighton,et al. MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma research , 2007, Breast Cancer Research and Treatment.
[24] D. Richardson,et al. The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. , 2006, Carcinogenesis.
[25] M. Yamaguchi,et al. 17β-Estradiol Induces Down-Regulation of Cap43/NDRG1/Drg-1, a Putative Differentiation-Related and Metastasis Suppressor Gene, in Human Breast Cancer Cells , 2006, Clinical Cancer Research.
[26] C. Logothetis,et al. Stem-cell origin of metastasis and heterogeneity in solid tumours. , 2002, The Lancet. Oncology.
[27] K. Friedrichs,et al. High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. , 1995, Cancer research.
[28] R. Eils,et al. From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Składanowski,et al. Expression of ecto-5′-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma , 2006, Melanoma research.
[30] K. Iczkowski,et al. Inhibition of Macrophage Migration Inhibitory Factor or Its Receptor (CD74) Attenuates Growth and Invasion of DU-145 Prostate Cancer Cells1 , 2006, The Journal of Immunology.
[31] D. Tarin,et al. Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications , 2007, Molecular oncology.
[32] S. Goodison,et al. CD44 cell adhesion molecules. , 1999, Molecular pathology : MP.
[33] B. Mitchell,et al. The 5'-nucleotidases as regulators of nucleotide and drug metabolism. , 2005, Pharmacology & therapeutics.
[34] S. Jalkanen,et al. Differential Regulation and Function of CD73, a Glycosyl-Phosphatidylinositol–linked 70-kD Adhesion Molecule, on Lymphocytes and Endothelial Cells , 1997, The Journal of cell biology.
[35] P. Herrlich,et al. Splicing choice from ten variant exons establishes CD44 variability. , 1993, Nucleic acids research.
[36] D. Tarin,et al. Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines. , 2002, Anticancer research.
[37] E. Birney,et al. The International Protein Index: An integrated database for proteomics experiments , 2004, Proteomics.
[38] A. Hubbard,et al. Isolation of rat hepatocyte plasma membranes. II. Identification of membrane-associated cytoskeletal proteins , 1983, The Journal of cell biology.
[39] C. Perou,et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. , 2005, Cancer research.
[40] Leia M. Smith,et al. Lipid rafts remodeling in estrogen receptor–negative breast cancer is reversed by histone deacetylase inhibitor , 2006, Molecular Cancer Therapeutics.
[41] Matthias Mann,et al. Mass spectrometric-based approaches in quantitative proteomics. , 2003, Methods.
[42] S. Goodison,et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[43] J. Spychała. Tumor-promoting functions of adenosine. , 2000, Pharmacology & therapeutics.
[44] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[45] M. Humphries,et al. Integrin adhesion receptors: structure, function and implications for biomedicine. , 1996, Molecular medicine today.
[46] Z. Ou,et al. RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion , 2007, Clinical & Experimental Metastasis.
[47] Dao-Hai Zhang,et al. Proteomics of breast cancer: Enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors , 2005, Proteomics.
[48] S. Goodison,et al. Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[49] Thomas Kirchner,et al. Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.
[50] F. Bosman,et al. Expression of NDRG1, a differentiation-related gene, in human tissues , 2002, Histochemistry and Cell Biology.
[51] G Leclercq,et al. Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics. , 2004, Endocrine-related cancer.
[52] Ken Saito,et al. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression , 2004, Oncogene.
[53] P. Højrup,et al. VEMS 3.0: algorithms and computational tools for tandem mass spectrometry based identification of post-translational modifications in proteins. , 2005, Journal of proteome research.
[54] S. Goodison,et al. Breast tumor metastasis: analysis via proteomic profiling , 2008, Expert review of proteomics.
[55] A. Jemal,et al. Global Cancer Statistics , 2011 .
[56] J. Thiery,et al. Integrins in Mammary Gland Development and Differentiation of Mammary Epithelium , 2003, Journal of Mammary Gland Biology and Neoplasia.
[57] Gordon B Mills,et al. Lineage Infidelity of MDA-MB-435 Cells , 2004, Cancer Research.
[58] Charles Darwin,et al. Experiments , 1800, The Medical and physical journal.
[59] D. Tarin,et al. Tumor–stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis , 2006, International journal of cancer.
[60] D. Tarin,et al. Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model. , 2005, The American journal of pathology.
[61] J. Peterse,et al. Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.
[62] H. Bailey,et al. Expression of CD44s, CD44v6, and Hyaluronan Across the Spectrum of Normal-hyperplasia-carcinoma in Breast , 2008, Applied immunohistochemistry & molecular morphology : AIMM.
[63] B. Mitchell,et al. Role of Estrogen Receptor in the Regulation of Ecto-5′-Nucleotidase and Adenosine in Breast Cancer , 2004, Clinical Cancer Research.
[64] Robin L. Anderson,et al. Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone , 2006, Breast Cancer Research.
[65] D. Ross,et al. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma , 2007, Modern Pathology.
[66] Baocun Sun,et al. Identification of Metastasis-Related Proteins and Their Clinical Relevance to Triple-Negative Human Breast Cancer , 2008, Clinical Cancer Research.